OpenVSafe by OpenVAERS
Search V-safe

A2E-25229-48980

2 vaccinations 11 coded responses 22 check-ins 11 free-text entries 5 call cases
Sex
Female
Age at first dose
56-60
ZIP prefix
060 / CT
Registered
2020-12-30
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-29
    Dose 1 — Pfizer-BioNTech
  2. 2020-12-30
    Registered in v-safe
  3. 2020-12-30
    Survey response — days 1–6 daily, dose 1
    MedDRA: Dizziness, Headache — Feeling: Good · Site: Swelling · Diarrhea
    Free text: Back of head mild ache with mild lightheadedness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2020-12-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-01-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  6. 2021-01-01
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  7. 2021-01-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-01-05
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-01-12
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-01-15
    Dose 2 — Pfizer-BioNTech
  13. 2021-01-16
    Survey response — days 1–6 daily, dose 2
    MedDRA: Chest discomfort — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Chest discomfort
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-01-16
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  15. 2021-01-17
    Survey response — days 1–6 daily, dose 2
    MedDRA: Palpitations — Feeling: Good · Site: Swelling · Fever · Headache, Fatigue or tiredness
    Free text: Racing heart
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-01-18
    Survey response — days 1–6 daily, dose 2
    MedDRA: Palpitations — Feeling: Good · Fever · Headache, Muscle or body aches, Fatigue or tiredness
    Free text: Palpitations
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-01-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Nausea, Diarrhea, Abdominal pain
    Adult check-in
  18. 2021-01-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fever · Headache, Nausea, Vomiting, Diarrhea, Abdominal pain
    Adult check-in
  19. 2021-01-22
    Health check-in — day 7, dose 2
    Feeling: Fair · Headache, Diarrhea
    Adult check-in
  20. 2021-01-29
    Survey response — day 14, dose 2
    MedDRA: Headache, Nausea, Paraesthesia, Peripheral swelling, Vomiting — Feeling: Fair · Be unable to work
    Free text: Constant headache, tingling in both hands nauseous vomiting swelling in feet and hands
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-02-05
    Survey response — day 21, dose 2
    MedDRA: Headache, Paraesthesia — Feeling: Poor · Be unable to work
    Free text: Continuous headaches tingling in hands
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-02-12
    Survey response — day 28, dose 2
    MedDRA: Headache, Lymphadenopathy, Vision blurred — Feeling: Poor · Be unable to work
    Free text: Swollen glands constant headache blurred vision
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-02-19
    Survey response — day 35, dose 2
    MedDRA: Headache, Unevaluable event — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Headache 24/7 · Healthcare visit (other): Lots of tests
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  24. 2021-02-19
    Report sent to call center — day 35, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  25. 2021-02-26
    Survey response — day 42, dose 2
    MedDRA: Headache, Paraesthesia — Feeling: Poor · Be unable to work
    Free text: Consistent headache daily, hands tingling
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  26. 2021-04-16
    Survey response — 3 months, dose 2
    MedDRA: Office visit, Paraesthesia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: Tingling in my hands moved to my wrist. · Healthcare visit (other): Dr office
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  27. 2021-04-16
    Report sent to call center — 3 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  28. 2021-06-07
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact
  29. 2021-07-16
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  30. 2022-01-15
    Survey response — 12 months, dose 2
    MedDRA: Adenoidal hypertrophy, Lymphadenopathy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Enlarged adenoids and glands
    MedDRA releases: 2024-11 · check-in free text available
  31. 2022-01-15
    Report sent to call center — 12 months, dose 2
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  32. 2022-01-17
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Vaccinations

DoseDateManufacturerCo-administered
12020-12-29Pfizer-BioNTech
22021-01-15Pfizer-BioNTech

Call center

5 call center cases

3 successful · 2 priority 2/3 (triaged and no follow up)

VAERS report filed, before or during a call: 2

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 1

2020-12-30

Systemic reaction (other): Back of head mild ache with mild lightheadedness

Release 2 — days 1–6 daily, dose 2

2021-01-16

Systemic reaction (other): Chest discomfort

2021-01-17

Systemic reaction (other): Racing heart

2021-01-18

Systemic reaction (other): Palpitations

Release 3 — day 14, dose 2

2021-01-29

Symptoms: Constant headache, tingling in both hands nauseous vomiting swelling in feet and hands

Release 3 — day 21, dose 2

2021-02-05

Symptoms: Continuous headaches tingling in hands

Release 4 — day 28, dose 2

2021-02-12

Symptoms: Swollen glands constant headache blurred vision

Release 4 — day 35, dose 2

2021-02-19

Symptoms: Headache 24/7
Healthcare visit (other): Lots of tests

Release 4 — day 42, dose 2

2021-02-26

Symptoms: Consistent headache daily, hands tingling

Release 7 — 3 months, dose 2

2021-04-16

Symptoms: Tingling in my hands moved to my wrist.
Healthcare visit (other): Dr office

Release 10 — 12 months, dose 2

2022-01-15

Symptoms: Enlarged adenoids and glands

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit ✓ ✓ ✓
HCVOUnevaluable event ✓ ✓ ✓
SDAdenoidal hypertrophy · · ✓
SDHeadache ✓ ✓ ✓
SDLymphadenopathy ✓ ✓ ✓
SDNausea ✓ ✓ ✓
SDParaesthesia ✓ ✓ ✓
SDPeripheral swelling ✓ ✓ ✓
SDVision blurred ✓ ✓ ✓
SDVomiting ✓ ✓ ✓
SROChest discomfort ✓ ✓ ✓
SRODizziness ✓ ✓ ✓
SROHeadache ✓ ✓ ✓
SROPalpitations ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release